Frazier Life Sciences Holdings II LLC Discloses Investment at Frazier Life Sciences Acquisition Corp. II with 20.5% Stake

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Frazier Life Sciences Holdings II LLC disclosed a 20.5% stake in Frazier Life Sciences Acquisition Corp. II. The position reflects shares acquired before and alongside the SPAC’s October 15, 2026 IPO, including 300,000 Class A shares bought in a private placement. The sponsor also holds Class B founder shares that can convert into Class A at the time of a business combination.

Investor Intent

Frazier Life Sciences Holdings II LLC says it holds the shares for investment and may buy or sell more. The sponsor may talk with other shareholders about potential transactions and “the acquisition or disposition of Ordinary Shares, including through derivative transactions.”

The sponsor also keeps its options open on strategic moves, including changes to leadership or a deal. It may consider “an extraordinary corporate transaction, such as a merger, reorganization or liquidation,” though it reports no specific plans today.

Investor's Background

Frazier Life Sciences Holdings II LLC is a Cayman Islands entity affiliated with Frazier Life Sciences, a venture platform focused on healthcare and biotech. The firm invests across private and public life sciences companies with a hands-on approach to company building. Frazier-backed teams have launched and financed numerous therapeutics companies across drug development stages.

Original SEC Filing: Frazier Life Sciences Acquisition Corp. II [ FLSC ] - SCHEDULE 13D - Oct. 21, 2026

Disclaimer
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

Source: TradingView The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings